20 May 2013
Keywords: pfizer, drops, diabetic, neuropathy, drug, updated, said
Article | 18 October 2000
Pfizer has said it is suspending the development of its aldose reductaseinhibitor research candidate, zenarestat, which was being investigated
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 October 2000
19 October 2000
20 October 2000
© 2013 thepharmaletter.com